Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
CMX157
print preview
bookmark
share with colleague
General Information
Company
Chimerix Inc.
Description
Oral lipid acyclic nucleoside phosphonate that delivers high intracellular concentrations of the antiviral agent tenofovir diphosphate
Molecular Target
Viral polymerase
Mechanism of Action
Latest Stage of Development
Phase I
Indication
HIV / AIDS
Partner
Merck & Co. Inc.
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy